Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy: A six-month update

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 11-12, 2011, Pages 993-

  Crucitti, Antonio ^a   Tsai, Theodore F ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; INFLUENZA VACCINE; MIFAMURTIDE;

ALCOHOL CONSUMPTION; CATAPLEXY; CLINICAL TRIAL (TOPIC); DRUG SURVEILLANCE PROGRAM; FOLLOW UP; HUMAN; LETTER; MEDICAL HISTORY; NARCOLEPSY; REM SLEEP; SLEEP; TOBACCO;

ADJUVANTS, IMMUNOLOGIC; HUMANS; INFLUENZA VACCINES; NARCOLEPSY;

EID: 80755188006     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.608714     Document Type: Letter

References (1)

1. Tsai TF, Crucitti A, Nacci P, Nicolay U, Cioppa GD, Ferguson J, Clemens R. Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted infl uenza vaccines for associated cases of narcolepsy. Scand J Infect Dis 2011; May 2. [Epub ahead of print]